Solid Biosciences Inc. Uncategorized Contracts & Agreements
13 Contracts & Agreements
- Executive Chair Agreement, effective January 1, 2022, by and between Solid Biosciences Inc. and Ian F. Smith, as amended by the First Amendment to Executive Chair Agreement,... (Filed With SEC on March 13, 2024)
- Form of Parent Support Agreement (Filed With SEC on September 30, 2022)
- Executive Chair Agreement, effective January 1, 2022, by and between Solid Biosciences Inc. and Ian F. Smith (Filed With SEC on March 14, 2022)
- Investor Agreement, dated as of October 22, 2020, by and between the Company and Ultragenyx Pharmaceutical Inc (Filed With SEC on November 5, 2020)
- Description of the Companys Securities Registered under Section 12 of the Exchange Act (Filed With SEC on March 12, 2020)
- Plan of Conversion, dated January 25, 2018 (Filed With SEC on March 29, 2018)
- Amendment to Offer Letter, dated November 17, 2017, by and between Solid Biosciences, LLC and Jennifer Ziolkowski (Filed With SEC on January 16, 2018)
- Offer Letter, dated as of April 17, 2017, by and between Solid Biosciences, LLC and Jennifer Ziolkowski (Filed With SEC on January 16, 2018)
- Form of Plan of Conversion (Filed With SEC on January 16, 2018)
- Offer Letter, dated as of November 6, 2015, by and between Solid Biosciences, LLC and Alvaro Amorrortu (Filed With SEC on December 29, 2017)
- Offer Letter, dated as of November 17, 2015, by and between Solid GT, LLC and Jorge A. Quiroz, M.D (Filed With SEC on December 29, 2017)
- Form of Certificate of Conversion of Solid Biosciences, LLC (Filed With SEC on December 29, 2017)
- Form of Plan of Conversion (Filed With SEC on December 29, 2017)